Zentek (CVE:ZEN) Trading Up 41.8% - Should You Buy?

Key Points

• Zentek Ltd. (CVE:ZEN) shares surged by 41.8%, reaching a trading high of C$1.70 and closing at C$1.29, with trading volume jumping to 407,343 shares, a 752% increase from the average.
• The company, with a market cap of C$135.08 million, focuses on the research and development of graphene-based products including antimicrobial coatings, surgical masks, and diagnostic tests.
• Zentek has a negative price-to-earnings ratio of -16.13 and significant debt with a debt-to-equity ratio of 4.97.

Zentek Ltd. (CVE:ZEN - ) shares were up 41.8% on Tuesday . The stock traded as high as C$1.70 and last traded at C$1.29. Approximately 407,343 shares traded hands during trading, an increase of 752% from the average daily volume of 47,792 shares. The stock had previously closed at C$0.91.

Zentek Stock Up 41.8%

The firm has a market cap of C$135.08 million, a price-to-earnings ratio of -16.13 and a beta of 0.57. The firm's 50 day moving average price is C$1.23 and its two-hundred day moving average price is C$1.57. The company has a debt-to-equity ratio of 4.97, a current ratio of 2.06 and a quick ratio of 7.59.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.